<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04470000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P00740</UniProt_ID>
  <Seq_Length>461</Seq_Length>
  <Molecule_Weight>51778</Molecule_Weight>
  <KEGG_ID>hsa:2158</KEGG_ID>
  <Orthology_ID>K01321</Orthology_ID>
  <Function_Summary>Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa.</Function_Summary>
  <Catalytic_Mechanism>Selective cleavage of Arg-|-Ile bond in factor X to form factor Xa.</Catalytic_Mechanism>
  <Pfam_ID>PF00008:EGF@@PF00594:Gla@@PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Coagulation factor IXa heavy chain</Alias>
      <Alias>Plasma thromboplastin component</Alias>
      <Alias>PTC</Alias>
      <Alias>Christmas factor</Alias>
      <Alias>Coagulation factor IXa light chain</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calcium ions (Ca2+).</Detail>
      <Keyword>Calcium ion binding</Keyword>
      <Ontology_ID>GO:0005509</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>442</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>431</Position>
      <Original>Trp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>449</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>383</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>383</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>435</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>106</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>433</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>426</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>424</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>404</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>91</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>442</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>387</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>351</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>390</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>30</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>119</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>119</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>108</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>321</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>344</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>396</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>412</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>411</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>357</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>356</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>54</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>382</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>411</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>394</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>396</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>461</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>366</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>414</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>454</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>432</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>431</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>407</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>397</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>430</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>362</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>432</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>395</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>71</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>106</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>419</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>453</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>55</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>333</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>413</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>436</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>450</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>433</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>279</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>357</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>101</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>407</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>443</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>318</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>363</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>316</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>395</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>384</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>449</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>333</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>410</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.</Detail>
      <Keyword>Blood coagulation, intrinsic pathway</Keyword>
      <Ontology_ID>GO:0007597</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The covalent alteration of one or more amino acids occurring in a protein after the protein has been completely translated and released from the ribosome.</Detail>
      <Keyword>Post-translational protein modification</Keyword>
      <Ontology_ID>GO:0043687</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.</Detail>
      <Keyword>Blood coagulation, extrinsic pathway</Keyword>
      <Ontology_ID>GO:0007598</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.</Detail>
      <Keyword>Hemostasis</Keyword>
      <Ontology_ID>GO:0007599</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.</Detail>
      <Keyword>Peptidyl-glutamic acid carboxylation</Keyword>
      <Ontology_ID>GO:0017187</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>61</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>86</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>72</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>82</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>67</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>53</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>76</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>110</Position>
      <PTM_Type>(3R)-3-hydroxyaspartate</PTM_Type>
    </PTM>
    <PTM>
      <Position>66</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>73</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>201</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>63</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>79</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
    <PTM>
      <Position>204</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>114</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>54</Position>
      <PTM_Type>4-carboxyglutamate</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSGKLEEFVQGNLERECMEEKCSFEEAREVFENTERTTEFWKQYVDGDQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTRAETVFPDVDYVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT</Protein_Seq>
    <DNA_Seq>ACCACTTTCACAATCTGCTAGCAAAGGTTATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACTTAATGAAAGATGGATTTCCAAGGTTAATTCATTGGAATTGAAAATTAACAGGGCCTCTCACTAACTAATCACTTTCCCATCTTTTGTTAGATTTGAATATATACATTCTATGATCATTGCTTTTTCTCTTTACAGGGGAGAATTTCATATTTTACCTGAGCAAATTGATTAGAAAATGGAACCACTAGAGGAATATAATGTGTTAGGAAATTACAGTCATTTCTAAGGGCCCAGCCCTTGACAAAATTGTGAAGTTAAATTCTCCACTCTGTCCATCAGATACTATGGTTCTCCACTATGGCAACTAACTCACTCAATTTTCCCTCCTTAGCAGCATTCCATCTTCCCGATCTTCTTTGCTTCTCCAACCAAAACATCAATGTTTATTAGTTCTGTATACAGTACAGGATCTTTGGTCTACTCTATCACAAGGCCAGTACCACACTCATGAAGAAAGAACACAGGAGTAGCTGAGAGGCTAAAACTCATCAAAAACACTACTCCTTTTCCTCTACCCTATTCCTCAATCTTTTACCTTTTCCAAATCCCAATCCCCAAATCAGTTTTTCTCTTTCTTACTCCCTCTCTCCCTTTTACCCTCCATGGTCGTTAAAGGAGAGATGGGGAGCATCATTCTGTTATACTTCTGTACACAGTTATACATGTCTATCAAACCCAGACTTGCTTCCGTAGTGGAGACTTGCTTTTCAGAACATAGGGATGAAGTAAGGTGCCTGAAAAGTTTGGGGGAAAAGTTTCTTTCAGAGAGTTAAGTTATTTTATATATATAATATATATATAAAATATATAATATACAATATAAATATATAGTGTGTGTGTATGCGTGTGTGTAGACACACACGCATACACACATATAATGGAAGCAATAAGCCATTCTAAGAGCTTGTATGGTTATGGAGGTCTGACTAGGCATGATTTCACGAAGGCAAGATTGGCATATCATTGTAACTAAAAAAGCTGACATTGACCCAGACATATTGTACTCTTTCTAAAAATAATAATAATAATGCTAACAGAAAGAAGAGAACCGTTCGTTTGCAATCTACAGCTAGTAGAGACTTTGAGGAAGAATTCAACAGTGTGTCTTCAGCAGTGTTCAGAGCCAAGCAAGAAGTTGAAGTTGCCTAGACCAGAGGACATAAGTATCATGTCTCCTTTAACTAGCATACCCCGAAGTGGAGAAGGGTGCAGCAGGCTCAAAGGCATAAGTCATTCCAATCAGCCAACTAAGTTGTCCTTTTCTGGTTTCGTGTTCACCATGGAACATTTTGATTATAGTTAATCCTTCTATCTTGAATCTTCTAGAGAGTTGCTGACCAACTGACGTATGTTTCCCTTTGTGAATTAATAAACTGGTGTTCTGGTTCAT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Plasma</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi lumen</CellLocal>
      <Ontology_ID>GO:0005796</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum lumen</CellLocal>
      <Ontology_ID>GO:0005788</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>F9</Gene_Name>
    <Gene_ID>2158</Gene_ID>
    <Genbank_ACCN>NM_000133</Genbank_ACCN>
    <Protein_ACCN>NP_000124</Protein_ACCN>
    <HGNC_ID>3551</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2158</Gene_URL>
    <UCSC_ID>uc004fas.1</UCSC_ID>
    <EMBL_ID>ENSG00000101981</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>RTN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_artery_occlusion?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bernard-Soulier Syndrome</Disease_Name>
      <Disease_Detail>Bernard-Soulier Syndrome</Disease_Detail>
      <Disease_DB>BRN019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bernard_soulier_syndrome?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Vii Deficiency</Disease_Name>
      <Disease_Detail>Factor Vii Deficiency</Disease_Detail>
      <Disease_DB>FCT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_vii_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Warfarin Resistance</Disease_Name>
      <Disease_Detail>Warfarin Resistance</Disease_Detail>
      <Disease_DB>WRF001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/warfarin_resistance?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Venous Thrombosis</Disease_Name>
      <Disease_Detail>Venous Thrombosis</Disease_Detail>
      <Disease_DB>VNS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thrombosis?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Warfarin Sensitivity</Disease_Name>
      <Disease_Detail>Warfarin Sensitivity</Disease_Detail>
      <Disease_DB>WRF002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/warfarin_sensitivity?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor X Deficiency</Disease_Name>
      <Disease_Detail>Factor X Deficiency</Disease_Detail>
      <Disease_DB>FCT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_x_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xii Deficiency</Disease_Name>
      <Disease_Detail>Factor Xii Deficiency</Disease_Detail>
      <Disease_DB>FCT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xii_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemarthrosis</Disease_Name>
      <Disease_Detail>Hemarthrosis</Disease_Detail>
      <Disease_DB>HMR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemarthrosis?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiac Tamponade</Disease_Name>
      <Disease_Detail>Cardiac Tamponade</Disease_Detail>
      <Disease_DB>CRD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiac_tamponade?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilic Arthropathy</Disease_Name>
      <Disease_Detail>Hemophilic Arthropathy</Disease_Detail>
      <Disease_DB>HMP018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilic_arthropathy?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombophilia, X-Linked, Due to Factor Ix Defect</Disease_Name>
      <Disease_Detail>Thrombophilia</Disease_Detail>
      <Disease_DB>THR055</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombophilia_x_linked_due_to_factor_ix_defect?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilia</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>HMP007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilia?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Symptomatic Form of Hemophilia B in Female Carriers</Disease_Name>
      <Disease_Detail>Symptomatic Form of Hemophilia B in Female Carriers</Disease_Detail>
      <Disease_DB>SYM021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/symptomatic_form_of_hemophilia_b_in_female_carriers?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xi Deficiency</Disease_Name>
      <Disease_Detail>Factor Xi Deficiency</Disease_Detail>
      <Disease_DB>FCT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xi_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Viii Deficiency</Disease_Name>
      <Disease_Detail>Factor Viii Deficiency</Disease_Detail>
      <Disease_DB>FCT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_viii_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemorrhagic Disease</Disease_Name>
      <Disease_Detail>Hemorrhagic Disease</Disease_Detail>
      <Disease_DB>HMR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemorrhagic_disease?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acquired Hemophilia</Disease_Name>
      <Disease_Detail>Acquired Hemophilia</Disease_Detail>
      <Disease_DB>ACQ014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acquired_hemophilia?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mild Hemophilia B</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>MLD014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mild_hemophilia_b?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arthropathy</Disease_Name>
      <Disease_Detail>Arthropathy</Disease_Detail>
      <Disease_DB>ART023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arthropathy?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Deep Venous Thrombosis, Protection Against</Disease_Name>
      <Disease_Detail>Deep Venous Thrombosis, Protection Against</Disease_Detail>
      <Disease_DB>DPV002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deep_venous_thrombosis_protection_against?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilia B</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>HMP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilia_b?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor V Deficiency</Disease_Name>
      <Disease_Detail>Factor V Deficiency</Disease_Detail>
      <Disease_DB>FCT006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_v_deficiency?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Hemophilia B</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>SVR057</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_hemophilia_b?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coumarin Resistance</Disease_Name>
      <Disease_Detail>Coumarin Resistance</Disease_Detail>
      <Disease_DB>CMR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coumarin_resistance?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Color Blindness</Disease_Name>
      <Disease_Detail>Color Blindness</Disease_Detail>
      <Disease_DB>CLR019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/color_blindness?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sneddon Syndrome</Disease_Name>
      <Disease_Detail>Sneddon Syndrome</Disease_Detail>
      <Disease_DB>SND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sneddon_syndrome?search=F9#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Moderately Severe Hemophilia B</Disease_Name>
      <Disease_Detail>Moderately Severe Hemophilia B</Disease_Detail>
      <Disease_DB>MDR008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/moderately_severe_hemophilia_b?search=F9#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>NMR STRUCTURE OF CALCIUM ION-BOUND GAMMA-CARBOXY-GLUTAMIC ACID-RICH DOMAIN OF FACTOR IX</PDB_Title>
      <PDB_ID>1CFI</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CFI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX.</PubMed_Title>
      <Author>Freedman, S.J., et al.</Author>
      <Journal>Biochemistry(1995)34:12126-12137</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7547952?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED</PDB_Title>
      <PDB_ID>2WPJ</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE METAL-FREE GAMMA-CARBOXYGLUTAMIC ACID-RICH MEMBRANE BINDING REGION OF FACTOR IX BY TWO-DIMENSIONAL NMR SPECTROSCOPY</PDB_Title>
      <PDB_ID>1CFH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CFH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy.</PubMed_Title>
      <Author>Freedman, S.J., et al.</Author>
      <Journal>J.Biol.Chem.(1995)270:7980-7987</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7713897?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE TRIPLE MUTANT</PDB_Title>
      <PDB_ID>2WPH</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Benzothiophene Inhibitors of Factor IXa</PDB_Title>
      <PDB_ID>3LC3</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LC3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Studies of Benzothiophene Template as Potent Factor IXa (FIXa) Inhibitors in Thrombosis.</PubMed_Title>
      <Author>Wang, S., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:1465-1472</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20121198?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the antithrombin-factor IXa-pentasaccharide complex</PDB_Title>
      <PDB_ID>3KCG</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KCG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220038</ASD_Ligand>
      <PubMed_Title>Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.</PubMed_Title>
      <Author>Johnson, D.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:645-650</Journal>
      <PubMed_ID>20080729</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED</PDB_Title>
      <PDB_ID>2WPK</PDB_ID>
      <Resolution>2.21</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED</PDB_Title>
      <PDB_ID>2WPL</PDB_ID>
      <Resolution>1.82</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Selective Benzothiophine Inhibitors of Factor IXa</PDB_Title>
      <PDB_ID>3LC5</PDB_ID>
      <Resolution>2.62</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LC5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure Based Drug Design: Development of Potent and Selective Factor IXa (FIXa) Inhibitors.</PubMed_Title>
      <Author>Wang, S., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:1473-1482</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20121197?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE</PDB_Title>
      <PDB_ID>1RFN</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RFN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.</PubMed_Title>
      <Author>Hopfner, K.P., et al.</Author>
      <Journal>Structure Fold.Des.(1999)7:989-996</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10467148?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE DOUBLE MUTANT</PDB_Title>
      <PDB_ID>2WPI</PDB_ID>
      <Resolution>1.99</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED</PDB_Title>
      <PDB_ID>2WPM</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WPM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor Ixa</PubMed_Title>
      <Author>Zogg, T., et al.</Author>
      <Journal>Structure(2009)17:1669-1678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20004170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COAGULATION FACTOR, MG(II), NMR, 7 STRUCTURES (BACKBONE ATOMS ONLY)</PDB_Title>
      <PDB_ID>1MGX</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MGX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.</PubMed_Title>
      <Author>Freedman, S.J., et al.</Author>
      <Journal>J.Biol.Chem.(1996)271:16227-16236</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8663165?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE THREE-DIMENSIONAL STRUCTURE OF THE FIRST EGF-LIKE MODULE OF HUMAN FACTOR IX: COMPARISON WITH EGF AND TGF-A</PDB_Title>
      <PDB_ID>1IXA</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IXA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha.</PubMed_Title>
      <Author>Baron, M., et al.</Author>
      <Journal>Protein Sci.(1992)1:81-90</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1304885?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12</PDB_Title>
      <PDB_ID>1NL0</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NL0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Calcium-stabilized Human Factor IX Gla Domain Bound to a Conformation-specific Anti-factor IX Antibody.</PubMed_Title>
      <Author>Huang, M., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:14338-14346</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14722079?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX</PDB_Title>
      <PDB_ID>1EDM</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EDM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions.</PubMed_Title>
      <Author>Rao, Z., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1995)82:131-141</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7606779?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Small proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.h.c.bb.b.b.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1rfn</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,379,Arg</Site_Detail>
      <Site_Reference>Misenheimer TM, et al. Biochemistry. 2007,46(26):7886-7895.</Site_Reference>
      <PubMed_ID>17563121</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.21.22</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/22.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02930001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>